Advertisement

Updated April 12th, 2023 at 18:15 IST

COVID case surge in India prompts Serum Institute to restart making Covishield

Serum Institute of India CEO Adar Poonawalla said it has restarted manufacturing of COVID-19 vaccine Covishield amid rising numbers of cases of the virus infection.

Image: AP | Image:self
Advertisement

Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday said it has restarted manufacturing of COVID-19 vaccine Covishield amid rising numbers of cases of the virus infection.

He said the company already has six million booster doses of Covovax vaccine available and adults must take the booster shot.

Reacting to reports of COVID-19 vaccines shortage, he said manufacturers are ready but there has been no demand.

"Just as a precaution, at risk we have done it so that people have a Covishield as a choice if they want it," Poonawalla told PTI on restarting of manufacturing of the vaccine.

The company had stopped manufacturing of Covishield in December 2021.

On Covovax which has been approved as a booster dose for 18-years and above, he said, "We have six million doses ready but the demand is exactly zero." Covovax booster is now on the CoWin app, he said.

Advertisement

Published April 12th, 2023 at 18:15 IST

Your Voice. Now Direct.

Send us your views, we’ll publish them. This section is moderated.

Advertisement
Advertisement

Trending Quicks

Advertisement
Advertisement
Advertisement
Whatsapp logo